UBS Group
RGDX

UBS Group’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

UBS Group’s Portfolio RGDX Stock Details RGDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,621
Closed -$5K – 9060
2015
Q2 		$5K Buy
16,621
+9,707
+140% +$3.29K ﹤0.01% 7929
2015
Q1 		$3K Buy
+6,914
New +$3.08K ﹤0.01% 8399

UBS Group's RGDX Position: Q3 2015 in Review

UBS Group sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 16,621 shares — an estimated $5K sold.

UBS Group first reported a position in RGDX in Q1 2015 and held it in 2 quarters. The position peaked at $5K in Q2 2015. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

  • UBS Group reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
  • UBS Group sold 16,621 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $5K.
  • UBS Group first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q1 2015 and held it in 2 quarters.
  • UBS Group's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $5K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.